These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 318096)

  • 1. Immune responses in yersinia-associated reactive arthritis.
    Aho K; Ahvonen P; Juvakoski T; Kousa M; Leirisalo M; Laitinen O
    Ann Rheum Dis; 1979; 38 Suppl 1(Suppl 1):suppl 123-6. PubMed ID: 318096
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogen antigen- and superantigen-reactive synovial fluid T cells in reactive arthritis.
    Lahesmaa R; Soderberg C; Bliska J; Allsup A; Luukkainen R; Steinman L; Uchiyama T; Peltz G
    J Infect Dis; 1995 Nov; 172(5):1290-7. PubMed ID: 7594666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yersinia antibodies in inflammatory joint diseases.
    Granfors K; Isomäki H; von Essen R; Maatela J; Kalliomäki JL; Toivanen A
    Clin Exp Rheumatol; 1983; 1(3):215-8. PubMed ID: 6335856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis.
    Hermann E; Fleischer B; Mayet WJ; Poralla T; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1989 Mar; 75(3):365-70. PubMed ID: 2467775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do bacterial antigens persist in patients with reactive arthritis?].
    Toivanen A; Viitanen AM; Stälberg TH; Pulkkinen L; Lahesmaa-Rantala R
    Ter Arkh; 1986; 58(7):26-9. PubMed ID: 3764736
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects.
    Toivanen A; Granfors K; Lahesmaa-Rantala R; Leino R; Ståhlberg T; Vuento R
    Immunol Rev; 1985 Aug; 86():47-70. PubMed ID: 3930389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis.
    Merilahti-Palo R; Söderström KO; Lahesmaa-Rantala R; Granfors K; Toivanen A
    Ann Rheum Dis; 1991 Feb; 50(2):87-90. PubMed ID: 1998396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of persistent Yersinia antibodies of the IgA class].
    Granfors K; Ogasawara M; Stälberg TH; Toivanen O; Yu D
    Ter Arkh; 1986; 58(7):24-6. PubMed ID: 3764735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Yersinia arthritis. Long-term follow up].
    Herrlinger JD; Asmussen JU
    Z Rheumatol; 1993; 52(4):210-4. PubMed ID: 8212919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
    Bucknall R; Leirisalo-Repo M; Laitinen O; Jones JV
    Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and bacteriological aspects of reactive arthritis.
    Toivanen A; Granfors K; Lahesmaa-Rantala R; Toivanen P
    Rheumatol Int; 1989; 9(3-5):201-3. PubMed ID: 2692127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis.
    Ståhlberg TH; Heesemann J; Granfors K; Toivanen A
    Ann Rheum Dis; 1989 Jul; 48(7):577-81. PubMed ID: 2774698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tetrapeptide shared by Yersinia outer membrane protein Yop1 and HLA-B27. Antibody response in patients with Yersinia-triggered reactive arthritis.
    Lahesmaa R; Skurnik M; Granfors K; Möttönen T; Saario R; Toivanen A; Toivanen P
    Scand J Rheumatol Suppl; 1990; 87():70-1. PubMed ID: 1701921
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of Reiter's syndrome, with special emphasis on Yersinia enterocolitica.
    Yu DT; Ogasawara M; Hill JL; Kono DH
    Immunol Rev; 1985 Aug; 86():27-45. PubMed ID: 3876266
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter's syndrome. Lack of response in other HLA-B27 positive individuals.
    Brenner MB; Kobayashi S; Wiesenhutter CW; Huberman AK; Bales P; Yu DT
    Arthritis Rheum; 1984 Mar; 27(3):250-7. PubMed ID: 6608353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia reactive arthritis.
    Aho K
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):41-5. PubMed ID: 6360291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of IgA class anti-yersinia antibodies in yersinia arthritis.
    Granfors K; Ståhlberg TH; Isomäki O; Toivanen A
    Scand J Rheumatol Suppl; 1987; 67():64-6. PubMed ID: 3483075
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.
    Toivanen A; Lahesmaa-Rantala R; Vuento R; Granfors K
    Ann Rheum Dis; 1987 Dec; 46(12):898-901. PubMed ID: 3426298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yersinia arthritis, immune functions and histocompatibility antigens.
    Repo H; Leirisalo-Repo M; Gripenberg M; Koskimies S; Kontiainen S; Laitinen O
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I.
    Repo H; Leirisalo-Repo M
    Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.